
1. Nat Rev Immunol. 2004 Jun;4(6):420-31.

Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40.

Sugamura K(1), Ishii N, Weinberg AD.

Author information: 
(1)Department of Microbiology and Immunology, Tohoku University Graduate School
of Medicine, Sendai 980-8575, Japan. sugamura@mail.tains.tohoku.ac.jp

DOI: 10.1038/nri1371 
PMID: 15173831  [Indexed for MEDLINE]

